Abstract
To the Editor: The National Heart, Lung, and Blood Institute PETAL (Prevention and Early Treatment of Acute Lung Injury) Clinical Trials Network (Dec. 26 issue)1 conducted a placebo-controlled trial of early vitamin D3 supplementation in critically ill vitamin D–deficient patients at high risk for death (Vitamin D to Improve Outcomes by Leveraging Early Treatment [VIOLET] trial). The plasma concentration of total 25-hydroxyvitamin D is currently used as an indicator of vitamin D status. However, there has been debate about whether measurement of total 25-hydroxyvitamin D is appropriate for the assessment of vitamin D status in certain clinical situations.2 Serum 25-hydroxyvitamin . . .

This publication has 11 references indexed in Scilit: